ARX517

DB23076InvestigationalProtein Based Therapies

ARX517 is under investigation in clinical trial NCT04662580 (ARX517/JNJ-95298177 as Monotherapy or Combination Therapy in Subjects With Metastatic Prostate Cancer).

Mechanism: Pharmacologically active on Glutamate carboxypeptidase 2 and Tubulin
Curator reviewed
Code names: ARX517 · JNJ-95298177

Resolves to

Targets

Q04609FOLH1

What you can answer from here — as of June 27, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

2Clinical trialsPhase, status and sponsor resolved per trial

4+ReferencesStructured and connected to the statements they support

Which drugs share a target with ARX517, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account